Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima S Toussi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literatureSima S Toussi, Nancy Pan, Heather M Walters, et al.
Nature Microbiology|May 4, 2023
Therapeutics for COVID-19Sima S Toussi, Jennifer L Hammond, Brian S Gerstenberger, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|October 22, 2013
Measuring media use in college students with and without human immunodeficiency virus infectionAnn-Margaret Dunn-Navarra, Sima S Toussi, Elizabeth Cohn, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 31, 2016
NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α InhibitorsMonica I Ardura, Sima S Toussi, Jane D Siegel, et al.
Ebiomedicine|May 30, 2025
Role of human infection challenge studies (HICs) in drug development for respiratory syncytial virus (RSV): systematic review and meta-analysisProsenjit Kundu, Mark Quinn, Elaine Thomas, et al.
Diagnostic Microbiology and Infectious Disease|March 15, 2017
Blastomycosis during pregnancy: a case report and review of the literatureThomas Baker, Ami Patel, Pierre Halteh, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
(1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric PatientsChristine M Salvatore, Tempe K Chen, Sima S Toussi, et al.
Journal of Pediatric Orthopedics. Part B|April 20, 2013
Candida albicans osteomyelitis in an infant: a case report and literature reviewNancy Pan, Ronit Herzog, John S Blanco, et al.
Journal of Clinical Pharmacology|September 26, 2023
Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19Ravi Shankar P Singh, Robert R LaBadie, Sima S Toussi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 10, 2023
The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous AdministrationNarayan Cheruvu, Esther van Duijn, Pieter A Spigt, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literatureSima S Toussi, Nancy Pan, Heather M Walters, et al.
Nature Microbiology|May 4, 2023
Therapeutics for COVID-19Sima S Toussi, Jennifer L Hammond, Brian S Gerstenberger, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|October 22, 2013
Measuring media use in college students with and without human immunodeficiency virus infectionAnn-Margaret Dunn-Navarra, Sima S Toussi, Elizabeth Cohn, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 31, 2016
NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α InhibitorsMonica I Ardura, Sima S Toussi, Jane D Siegel, et al.
Ebiomedicine|May 30, 2025
Role of human infection challenge studies (HICs) in drug development for respiratory syncytial virus (RSV): systematic review and meta-analysisProsenjit Kundu, Mark Quinn, Elaine Thomas, et al.
Diagnostic Microbiology and Infectious Disease|March 15, 2017
Blastomycosis during pregnancy: a case report and review of the literatureThomas Baker, Ami Patel, Pierre Halteh, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
(1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric PatientsChristine M Salvatore, Tempe K Chen, Sima S Toussi, et al.
Journal of Pediatric Orthopedics. Part B|April 20, 2013
Candida albicans osteomyelitis in an infant: a case report and literature reviewNancy Pan, Ronit Herzog, John S Blanco, et al.
Journal of Clinical Pharmacology|September 26, 2023
Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19Ravi Shankar P Singh, Robert R LaBadie, Sima S Toussi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 10, 2023
The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous AdministrationNarayan Cheruvu, Esther van Duijn, Pieter A Spigt, et al.
Pageof 2